Each N-PORT filing of FHLC compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/329 positions became 337: 23 added (0.3% of the fund), 15 dropped (0.86%). Turnover proxy 6.2%. Largest increases: UnitedHealth Group Inc 3.97% to 5.43%; Johnson & Johnson 8.36% to 8.95%; Bristol-Myers Squibb Co 1.71% to 1.99%; CVS Health Corp 1.44% to 1.71%; Amgen Inc 2.81% to 3.02%; Merck & Co Inc 4.21% to 4.38%. Largest decreases: Boston Scientific Corp 2.12% to 1.38%; Eli Lilly & Co 12.74% to 12.14%; Thermo Fisher Scientific Inc 3.34% to 2.91%; Abbott Laboratories 2.91% to 2.55%; Medtronic PLC 2.02% to 1.68%; Danaher Corp 2.15% to 1.84%. New: Terns Pharmaceuticals Inc (0.05%), Erasca Inc (0.03%), Capricor Therapeutics Inc (0.03%), Alumis Inc (0.03%), Kodiak Sciences Inc (0.02%), EyePoint Inc (0.02%). Gone: Exact Sciences Corp (0.3%), Hologic Inc (0.25%), Avidity Biosciences Inc (0.12%), Amicus Therapeutics Inc (0.06%), Arcellx Inc (0.03%), Avadel Pharmaceuticals PLC (0.03%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 23 Jun 2026 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/318 positions became 329: 25 added (0.3% of the fund), 14 dropped (0.32%). Turnover proxy 6.2%. Largest increases: Eli Lilly & Co 11.29% to 12.74%; Johnson & Johnson 7.38% to 8.36%; Merck & Co Inc 3.51% to 4.21%; Gilead Sciences Inc 2.42% to 2.69%; Amgen Inc 2.61% to 2.81%; Bristol-Myers Squibb Co 1.52% to 1.71%. Largest decreases: UnitedHealth Group Inc 5.03% to 3.97%; Abbott Laboratories 3.49% to 2.91%; Intuitive Surgical Inc 3.11% to 2.76%; Boston Scientific Corp 2.42% to 2.12%; Alnylam Pharmaceuticals Inc 0.97% to 0.68%; Veeva Systems Inc 0.73% to 0.48%. New: Indivior Pharmaceuticals Inc (0.05%), Fortrea Holdings Inc (0.02%), Celcuity Inc (0.02%), Definium Therapeutics Inc (0.02%), Amylyx Pharmaceuticals Inc (0.02%), Dianthus Therapeutics Inc (0.01%). Gone: Merus NV (0.08%), Akero Therapeutics Inc (0.05%), Indivior PLC (0.05%), Premier Inc (0.04%), Tilray Brands Inc (0.02%), Metsera Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 24 Mar 2026 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/322 positions became 318: 12 added (0.13% of the fund), 16 dropped (0.16%). Turnover proxy 5%. Largest increases: UnitedHealth Group Inc 4.15% to 5.03%; Eli Lilly & Co 10.85% to 11.29%; Thermo Fisher Scientific Inc 3.21% to 3.48%; Insmed Inc 0.36% to 0.59%; CVS Health Corp 1.42% to 1.61%; AbbVie Inc 6.09% to 6.25%. Largest decreases: Abbott Laboratories 3.98% to 3.49%; Stryker Corp 2.46% to 1.99%; Boston Scientific Corp 2.82% to 2.42%; Vertex Pharmaceuticals Inc 2.14% to 1.77%; Amgen Inc 2.89% to 2.61%; Cigna Group/The 1.32% to 1.06%. New: Xeris Biopharma Holdings Inc (0.03%), Cidara Therapeutics Inc (0.02%), Trevi Therapeutics Inc (0.02%), Hinge Health Inc (0.01%), Sana Biotechnology Inc (0.01%), Akebia Therapeutics Inc (0.01%). Gone: Amedisys Inc (0.06%), 89bio Inc (0.02%), Fortrea Holdings Inc (0.01%), Mesa Laboratories Inc (0.01%), Cross Country Healthcare Inc (0.01%), Cytek Biosciences Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 22 Dec 2025 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/341 positions became 322: 6 added (0.15% of the fund), 25 dropped (0.22%). Turnover proxy 6.7%. Largest increases: Johnson & Johnson 6.42% to 7.23%; Thermo Fisher Scientific Inc 2.8% to 3.21%; Alnylam Pharmaceuticals Inc 0.58% to 0.93%; Gilead Sciences Inc 2.27% to 2.55%; Stryker Corp 2.19% to 2.46%; Medtronic PLC 1.86% to 2.11%. Largest decreases: UnitedHealth Group Inc 6.46% to 4.15%; Eli Lilly & Co 12.38% to 10.85%; Elevance Health Inc 1.66% to 1.17%; Cigna Group/The 1.61% to 1.32%; Centene Corp 0.52% to 0.24%; Molina Healthcare Inc 0.32% to 0.16%. New: Tempus AI Inc (0.08%), Indivior PLC (0.04%), Metsera Inc (0.01%), uniQure NV (0.01%), Mineralys Therapeutics Inc (0.01%), Nutex Health Inc (0.01%). Gone: Blueprint Medicines Corp (0.1%), SpringWorks Therapeutics Inc (0.05%), EyePoint Pharmaceuticals Inc (0.01%), Altimmune Inc (0.01%), Verve Therapeutics Inc (0.01%), Varex Imaging Corp (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 24 Sep 2025 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/364 positions became 341: 7 added (0.05% of the fund), 30 dropped (0.43%). Turnover proxy 6.8%. Largest increases: Eli Lilly & Co 10.53% to 12.38%; AbbVie Inc 5.22% to 5.88%; Johnson & Johnson 5.89% to 6.42%; Vertex Pharmaceuticals Inc 1.92% to 2.24%; Gilead Sciences Inc 1.95% to 2.27%; McKesson Corp 1.24% to 1.54%. Largest decreases: UnitedHealth Group Inc 8.05% to 6.46%; Thermo Fisher Scientific Inc 3.67% to 2.8%; Merck & Co Inc 4.03% to 3.68%; Bristol-Myers Squibb Co 1.92% to 1.74%; Agilent Technologies Inc 0.7% to 0.52%; West Pharmaceutical Services Inc 0.4% to 0.26%. New: Anavex Life Sciences Corp (0.01%), Axogen Inc (0.01%), CorMedix Inc (0.01%), Butterfly Network Inc (0.01%), Ceribell Inc (0%), Septerna Inc (0%). Gone: Intra-Cellular Therapies Inc (0.19%), Inari Medical Inc (0.07%), Patterson Cos Inc (0.04%), Chicago Mercantile Exchange (0.02%), Avid Bioservices Inc (0.01%), Paragon 28 Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 25 Jun 2025 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/361 positions became 364: 15 added (0.14% of the fund), 12 dropped (0.33%). Turnover proxy 4.6%. Largest increases: Boston Scientific Corp 1.99% to 2.42%; Abbott Laboratories 3.18% to 3.58%; Intuitive Surgical Inc 2.88% to 3.27%; Thermo Fisher Scientific Inc 3.36% to 3.67%; McKesson Corp 1.05% to 1.24%; Stryker Corp 1.97% to 2.16%. Largest decreases: AbbVie Inc 5.8% to 5.22%; UnitedHealth Group Inc 8.37% to 8.05%; Johnson & Johnson 6.2% to 5.89%; Danaher Corp 2.64% to 2.33%; Amgen Inc 2.77% to 2.47%; Regeneron Pharmaceuticals Inc 1.46% to 1.17%. New: Concentra Group Holdings Parent Inc (0.04%), Waystar Holding Corp (0.03%), Chicago Mercantile Exchange (0.02%), Adaptive Biotechnologies Corp (0.01%), Capricor Therapeutics Inc (0.01%), ArriVent Biopharma Inc (0.01%). Gone: Catalent Inc (0.17%), Axonics Inc (0.06%), R1 RCM Inc (0.04%), Longboard Pharmaceuticals Inc (0.03%), MaxCyte Inc (0.01%), CryoPort Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 20 Mar 2025 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/365 positions became 361: 15 added (0.18% of the fund), 19 dropped (0.18%). Turnover proxy 5.1%. Largest increases: AbbVie Inc 5.19% to 5.8%; Eli Lilly & Co 10.29% to 10.8%; Intuitive Surgical Inc 2.49% to 2.88%; Bristol-Myers Squibb Co 1.53% to 1.82%; Gilead Sciences Inc 1.5% to 1.78%; Boston Scientific Corp 1.72% to 1.99%. Largest decreases: Danaher Corp 3.09% to 2.64%; Elevance Health Inc 1.96% to 1.52%; Regeneron Pharmaceuticals Inc 1.84% to 1.46%; Merck & Co Inc 4.54% to 4.18%; Thermo Fisher Scientific Inc 3.71% to 3.36%; Moderna Inc 0.61% to 0.29%. New: Clover Health Investments Corp (0.03%), Harrow Inc (0.02%), PACS Group Inc (0.02%), Avadel Pharmaceuticals PLC (0.02%), CareDx Inc (0.02%), Kiniksa Pharmaceuticals International Plc (0.01%). Gone: Cerevel Therapeutics Holdings Inc (0.05%), Morphic Holding Inc (0.03%), Kiniksa Pharmaceuticals International Plc (0.02%), Silk Road Medical Inc (0.02%), Atrion Corp (0.01%), PetIQ Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 26 Dec 2024 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/367 positions became 365: 22 added (0.48% of the fund), 24 dropped (0.65%). Turnover proxy 5.5%. Largest increases: UnitedHealth Group Inc 7.59% to 8.41%; Amgen Inc 2.49% to 2.82%; AbbVie Inc 4.87% to 5.19%; Vertex Pharmaceuticals Inc 1.72% to 2.03%; Intuitive Surgical Inc 2.21% to 2.49%; Pfizer Inc 2.45% to 2.73%. Largest decreases: Merck & Co Inc 5.55% to 4.54%; Dexcom Inc 0.83% to 0.41%; Eli Lilly & Co 10.69% to 10.29%; CVS Health Corp 1.48% to 1.2%; Edwards Lifesciences Corp 0.87% to 0.6%; Abbott Laboratories 3.12% to 2.91%. New: Labcorp Holdings Inc (0.29%), Nurix Therapeutics Inc (0.02%), Kiniksa Pharmaceuticals International Plc (0.02%), Arcutis Biotherapeutics Inc (0.02%), Silk Road Medical Inc (0.02%), Praxis Precision Medicines Inc (0.01%). Gone: Laboratory Corp of America Holdings (0.29%), Shockwave Medical Inc (0.21%), Alpine Immune Sciences Inc (0.04%), Fusion Pharmaceuticals Inc (0.02%), Deciphera Pharmaceuticals Inc (0.01%), Inhibrx Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 25 Sep 2024 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/365 positions became 367: 15 added (0.57% of the fund), 13 dropped (0.67%). Turnover proxy 5.3%. Largest increases: Eli Lilly & Co 8.8% to 10.69%; Merck & Co Inc 5.18% to 5.55%; Cigna Group/The 1.51% to 1.77%; Boston Scientific Corp 1.57% to 1.79%; Thermo Fisher Scientific Inc 3.51% to 3.73%; Elevance Health Inc 1.96% to 2.11%. Largest decreases: Johnson & Johnson 6.47% to 5.9%; UnitedHealth Group Inc 8.01% to 7.59%; Amgen Inc 2.84% to 2.49%; Gilead Sciences Inc 1.65% to 1.38%; Zoetis Inc 1.46% to 1.24%; Bristol-Myers Squibb Co 1.73% to 1.52%. New: Cooper Cos Inc/The (0.3%), Solventum Corp (0.16%), Fusion Pharmaceuticals Inc (0.02%), EyePoint Pharmaceuticals Inc (0.01%), MacroGenics Inc (0.01%), Spyre Therapeutics Inc (0.01%). Gone: Cooper Cos Inc/The (0.31%), Karuna Therapeutics Inc (0.17%), ImmunoGen Inc (0.12%), Cymabay Therapeutics Inc (0.03%), Veradigm Inc (0.02%), Chicago Mercantile Exchange (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 26 Jun 2024 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/403 positions became 365: 10 added (0.07% of the fund), 48 dropped (0.81%). Turnover proxy 5.8%. Largest increases: Intuitive Surgical Inc 1.75% to 2.25%; Eli Lilly & Co 8.52% to 8.8%; Danaher Corp 2.56% to 2.84%; Thermo Fisher Scientific Inc 3.27% to 3.51%; Amgen Inc 2.6% to 2.84%; Merck & Co Inc 4.97% to 5.18%. Largest decreases: UnitedHealth Group Inc 9.5% to 8.01%; Pfizer Inc 3.29% to 2.58%; Humana Inc 1.25% to 0.79%; Johnson & Johnson 6.81% to 6.47%; Bristol-Myers Squibb Co 2.06% to 1.73%; Cigna Group/The 1.74% to 1.51%. New: Edgewise Therapeutics Inc (0.01%), Amneal Pharmaceuticals Inc (0.01%), Apogee Therapeutics Inc (0.01%), Soleno Therapeutics Inc (0.01%), Standard BioTools Inc (0.01%), PetIQ Inc (0.01%). Gone: Seagen Inc (0.57%), Mirati Therapeutics Inc (0.05%), NextGen Healthcare Inc (0.02%), Point Biopharma Global Inc (0.02%), Intercept Pharmaceuticals Inc (0.01%), EQRx Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 Mar 2024 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/407 positions became 403: 11 added (0.06% of the fund), 15 dropped (0.64%). Turnover proxy 7.5%. Largest increases: Eli Lilly & Co 6.3% to 8.52%; UnitedHealth Group Inc 8.1% to 9.5%; Amgen Inc 2.14% to 2.6%; Merck & Co Inc 4.64% to 4.97%; Humana Inc 0.98% to 1.25%; Cigna Group/The 1.5% to 1.74%. Largest decreases: Johnson & Johnson 7.46% to 6.81%; Danaher Corp 3.03% to 2.56%; Thermo Fisher Scientific Inc 3.63% to 3.27%; Align Technology Inc 0.47% to 0.26%; Medtronic PLC 2% to 1.79%; Pfizer Inc 3.49% to 3.29%. New: MoonLake Immunotherapeutics (0.02%), Cabaletta Bio Inc (0.01%), Disc Medicine Inc (0.01%), iRadimed Corp (0.01%), ACELYRIN Inc (0.01%), Tactile Systems Technology Inc (0%). Gone: Horizon Therapeutics Plc (0.37%), Syneos Health Inc (0.08%), Reata Pharmaceuticals Inc (0.07%), NuVasive Inc (0.04%), Chinook Therapeutics Inc (0.03%), DICE Therapeutics Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 27 Dec 2023 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/430 positions became 407: 16 added (0.17% of the fund), 39 dropped (0.35%). Turnover proxy 4%. Largest increases: Eli Lilly & Co 5.51% to 6.3%; Danaher Corp 2.83% to 3.03%; UnitedHealth Group Inc 7.93% to 8.1%; Cigna Group/The 1.34% to 1.5%; Intuitive Surgical Inc 1.84% to 1.95%; IQVIA Holdings Inc 0.6% to 0.71%. Largest decreases: Merck & Co Inc 5.05% to 4.64%; Pfizer Inc 3.76% to 3.49%; Bristol-Myers Squibb Co 2.45% to 2.24%; Humana Inc 1.16% to 0.98%; Gilead Sciences Inc 1.78% to 1.63%; Thermo Fisher Scientific Inc 3.75% to 3.63%. New: Fortrea Holdings Inc (0.05%), 89bio Inc (0.01%), LifeStance Health Group Inc (0.01%), Amylyx Pharmaceuticals Inc (0.01%), Harrow Health Inc (0.01%), RxSight Inc (0.01%). Gone: Prometheus Biosciences Inc (0.08%), Oak Street Health Inc (0.07%), IVERIC bio Inc (0.06%), Heska Corp (0.02%), Figs Inc (0.01%), CTI BioPharma Corp (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 Sep 2023 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/442 positions became 430: 15 added (0.12% of the fund), 27 dropped (0.3%). Turnover proxy 4.5%. Largest increases: Eli Lilly & Co 4.76% to 5.51%; Merck & Co Inc 4.66% to 5.05%; Intuitive Surgical Inc 1.5% to 1.84%; Stryker Corp 1.48% to 1.76%; Medtronic PLC 1.91% to 2.09%; Boston Scientific Corp 1.13% to 1.29%. Largest decreases: Pfizer Inc 4.25% to 3.76%; CVS Health Corp 1.98% to 1.66%; Cigna Group/The 1.66% to 1.34%; Danaher Corp 3.13% to 2.83%; Moderna Inc 1% to 0.75%; Bristol-Myers Squibb Co 2.66% to 2.45%. New: Viking Therapeutics Inc (0.03%), Cymabay Therapeutics Inc (0.02%), Biohaven Ltd (0.01%), Ardelyx Inc (0.01%), Zymeworks Inc (0.01%), CONTRA SCILEX HLDG CO (0.01%). Gone: LHC Group Inc (0.08%), 1Life Healthcare Inc (0.04%), Signify Health Inc (0.03%), Meridian Bioscience Inc (0.03%), Myovant Sciences Ltd (0.02%), Albireo Pharma Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 22 Jun 2023 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/434 positions became 442: 27 added (0.68% of the fund), 19 dropped (0.26%). Turnover proxy 5.1%. Largest increases: Thermo Fisher Scientific Inc 3.49% to 3.83%; Abbott Laboratories 3.01% to 3.32%; Merck & Co Inc 4.44% to 4.66%; Horizon Therapeutics Plc 0.24% to 0.41%; IDEXX Laboratories Inc 0.52% to 0.69%; Stryker Corp 1.35% to 1.48%. Largest decreases: UnitedHealth Group Inc 9.04% to 8%; Johnson & Johnson 7.95% to 7.36%; Eli Lilly & Co 5.08% to 4.76%; Pfizer Inc 4.54% to 4.25%; Elevance Health Inc 2.29% to 2.06%; Bristol-Myers Squibb Co 2.86% to 2.66%. New: GE HealthCare Technologies Inc (0.43%), Doximity Inc (0.06%), Pliant Therapeutics Inc (0.03%), UFP Technologies Inc (0.01%), ADMA Biologics Inc (0.01%), Ventyx Biosciences Inc (0.01%). Gone: ABIOMED Inc (0.2%), Aerie Pharmaceuticals Inc (0.01%), Imago Biosciences Inc (0%), 4D Molecular Therapeutics Inc (0%), MacroGenics Inc (0%), Joint Corp/The (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 27 Mar 2023 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/443 positions became 434: 0 added (0% of the fund), 9 dropped (0.43%). Turnover proxy 5.7%. Largest increases: Merck & Co Inc 3.88% to 4.44%; Eli Lilly & Co 4.59% to 5.08%; Gilead Sciences Inc 1.29% to 1.71%; Regeneron Pharmaceuticals Inc 1.07% to 1.4%; Elevance Health Inc 1.98% to 2.29%; UnitedHealth Group Inc 8.77% to 9.04%. Largest decreases: Thermo Fisher Scientific Inc 4.02% to 3.49%; Danaher Corp 3.4% to 3.02%; Pfizer Inc 4.88% to 4.54%; Edwards Lifesciences Corp 1.08% to 0.78%; Abbott Laboratories 3.3% to 3.01%; Zoetis Inc 1.48% to 1.23%. Gone: Biohaven Pharmaceutical Holding Co Ltd (0.15%), Change Healthcare Inc (0.1%), Turning Point Therapeutics Inc (0.06%), Covetrus Inc (0.04%), Global Blood Therapeutics Inc (0.03%), ChemoCentryx Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 28 Dec 2022 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/473 positions became 443: 29 added (0.45% of the fund), 59 dropped (0.82%). Turnover proxy 4.7%. Largest increases: Danaher Corp 2.83% to 3.4%; Eli Lilly & Co 4.17% to 4.59%; UnitedHealth Group Inc 8.4% to 8.77%; Thermo Fisher Scientific Inc 3.82% to 4.02%; Moderna Inc 0.81% to 0.97%; Seagen Inc 0.31% to 0.43%. Largest decreases: Johnson & Johnson 8.33% to 7.88%; Medtronic PLC 2.46% to 2.13%; Abbott Laboratories 3.52% to 3.3%; AbbVie Inc 4.56% to 4.36%; Illumina Inc 0.77% to 0.58%; Stryker Corp 1.44% to 1.25%. New: QuidelOrtho Corp (0.09%), agilon health Inc (0.09%), R1 RCM Inc (0.06%), Roivant Sciences Ltd (0.02%), Definitive Healthcare Corp (0.02%), Enhabit Inc (0.01%). Gone: Cerner Corp (0.48%), Quidel Corp (0.07%), R1 RCM Inc (0.05%), Ortho Clinical Diagnostics Holdings PLC (0.04%), Tivity Health Inc (0.02%), Natus Medical Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 27 Sep 2022 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/475 positions became 473: 4 added (0.19% of the fund), 6 dropped (0.17%). Turnover proxy 5.6%. Largest increases: UnitedHealth Group Inc 7.63% to 8.4%; Eli Lilly & Co 3.42% to 4.17%; Johnson & Johnson 7.76% to 8.33%; Bristol-Myers Squibb Co 2.47% to 2.93%; AbbVie Inc 4.14% to 4.56%; Merck & Co Inc 3.53% to 3.93%. Largest decreases: Abbott Laboratories 3.87% to 3.52%; Danaher Corp 3.14% to 2.83%; Align Technology Inc 0.64% to 0.38%; Intuitive Surgical Inc 1.74% to 1.5%; Pfizer Inc 5.06% to 4.83%; Moderna Inc 0.99% to 0.81%. New: Azenta Inc (0.1%), Enovis Corp (0.05%), Embecta Corp (0.03%), Zimvie Inc (0.01%). Gone: Arena Pharmaceuticals Inc (0.09%), Vocera Communications Inc (0.05%), Triple-S Management Corp (0.02%), Apria Inc (0.01%), BioDelivery Sciences International Inc (0.01%), ALDER BIOPHARMACEUTICALS INC (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 23 Jun 2022 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/475 positions became 475: 32 added (0.21% of the fund), 32 dropped (0.62%). Turnover proxy 7.1%. Largest increases: Pfizer Inc 3.96% to 5.06%; AbbVie Inc 3.28% to 4.14%; Johnson & Johnson 6.94% to 7.76%; UnitedHealth Group Inc 7.04% to 7.63%; CVS Health Corp 1.9% to 2.41%; Bristol-Myers Squibb Co 2.11% to 2.47%. Largest decreases: Moderna Inc 1.91% to 0.99%; Intuitive Surgical Inc 2.08% to 1.74%; Dexcom Inc 0.98% to 0.71%; Medtronic PLC 2.62% to 2.38%; IDEXX Laboratories Inc 0.92% to 0.74%; Teladoc Health Inc 0.34% to 0.19%. New: Cano Health Inc (0.02%), Cross Country Healthcare Inc (0.01%), Figs Inc (0.01%), Agiliti Inc (0.01%), Cutera Inc (0.01%), iTeos Therapeutics Inc (0.01%). Gone: Hill-Rom Holdings Inc (0.17%), Acceleron Pharma Inc (0.15%), PPD Inc (0.09%), Inovalon Holdings Inc (0.05%), Magellan Health Inc (0.03%), Dicerna Pharmaceuticals Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 24 Mar 2022 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/475 positions became 475: 1 added (0.05% of the fund), 1 dropped (0.02%). Turnover proxy 4.6%. Largest increases: UnitedHealth Group Inc 6.42% to 7.04%; Thermo Fisher Scientific Inc 3.49% to 4.03%; Merck & Co Inc 3.19% to 3.61%; Abbott Laboratories 3.52% to 3.71%; Anthem Inc 1.54% to 1.72%; Dexcom Inc 0.81% to 0.98%. Largest decreases: Johnson & Johnson 7.43% to 6.94%; Bristol-Myers Squibb Co 2.49% to 2.11%; Amgen Inc 2.29% to 1.93%; Medtronic PLC 2.9% to 2.62%; Illumina Inc 1.19% to 0.98%; Biogen Inc 0.82% to 0.65%. New: Aurinia Pharmaceuticals Inc (0.05%). Gone: Translate Bio Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 21 Dec 2021 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/430 positions became 475: 62 added (1.04% of the fund), 17 dropped (0.98%). Turnover proxy 5.8%. Largest increases: Moderna Inc 0.88% to 1.84%; Eli Lilly & Co 2.8% to 3.25%; Danaher Corp 2.89% to 3.13%; Thermo Fisher Scientific Inc 3.31% to 3.49%; Illumina Inc 1.02% to 1.19%; ResMed Inc 0.48% to 0.65%. Largest decreases: UnitedHealth Group Inc 6.73% to 6.42%; Cigna Corp 1.6% to 1.32%; Abbott Laboratories 3.78% to 3.52%; Medtronic PLC 3.13% to 2.9%; Amgen Inc 2.48% to 2.29%; Johnson & Johnson 7.61% to 7.43%. New: Organon & Co (0.12%), Oak Street Health Inc (0.1%), Maravai LifeSciences Holdings Inc (0.06%), Cassava Sciences Inc (0.04%), Vir Biotechnology Inc (0.04%), Ortho Clinical Diagnostics Holdings PLC (0.03%). Gone: Alexion Pharmaceuticals Inc (0.66%), PRA Health Sciences Inc (0.19%), Cantel Medical Corp (0.06%), Luminex Corp (0.03%), Constellation Pharmaceuticals Inc (0.01%), iTeos Therapeutics Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 23 Sep 2021 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/434 positions became 430: 1 added (0.01% of the fund), 5 dropped (0.43%). Turnover proxy 5.3%. Largest increases: UnitedHealth Group Inc 5.86% to 6.73%; Medtronic PLC 2.76% to 3.13%; Anthem Inc 1.38% to 1.68%; Stryker Corp 1.38% to 1.58%; Intuitive Surgical Inc 1.62% to 1.81%; Boston Scientific Corp 0.94% to 1.11%. Largest decreases: Eli Lilly & Co 3.31% to 2.8%; Thermo Fisher Scientific Inc 3.73% to 3.31%; Johnson & Johnson 7.94% to 7.61%; Abbott Laboratories 4.04% to 3.78%; Merck & Co Inc 3.6% to 3.35%; Teladoc Health Inc 0.56% to 0.36%. New: ImmunityBio Inc (0.01%). Gone: Varian Medical Systems Inc (0.3%), HMS Holdings Corp (0.06%), BioTelemetry Inc (0.05%), GenMark Diagnostics Inc (0.02%), NantKwest Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Jun 2021 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/397 positions became 434: 51 added (1.36% of the fund), 14 dropped (0.7%). Turnover proxy 6.3%. Largest increases: Eli Lilly and Co 2.43% to 3.31%; Moderna Inc 0.4% to 0.88%; Illumina Inc 0.93% to 1.15%; Teladoc Health Inc 0.39% to 0.56%; Novavax Inc 0.1% to 0.25%; CVS Health Corp 1.58% to 1.73%. Largest decreases: Pfizer Inc 4.26% to 3.69%; Merck & Co Inc 4.1% to 3.6%; UnitedHealth Group Inc 6.25% to 5.86%; Danaher Corp 3.16% to 2.81%; Thermo Fisher Scientific Inc 4.04% to 3.73%; Bristol-Myers Squibb Co 2.86% to 2.56%. New: Viatris Inc (0.39%), 10X Genomics Inc (0.2%), Royalty Pharma PLC (0.1%), PPD Inc (0.07%), Bridgebio Pharma Inc (0.05%), ModivCare Inc (0.04%). Gone: MyoKardia Inc (0.24%), Mylan NV (0.16%), Livongo Health Inc (0.11%), Wright Medical Group NV (0.09%), Providence Service Corp/The (0.03%), Retrophin Inc (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 16 Mar 2021 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/403 positions became 397: 1 added (0.44% of the fund), 7 dropped (0.73%). Turnover proxy 5.6%. Largest increases: Thermo Fisher Scientific Inc 3.48% to 4.04%; Danaher Corp 2.69% to 3.16%; Abbott Laboratories 3.74% to 4.02%; Align Technology Inc 0.46% to 0.69%; UnitedHealth Group Inc 6.05% to 6.25%; Medtronic PLC 2.73% to 2.91%. Largest decreases: Vertex Pharmaceuticals Inc 1.49% to 1.17%; Eli Lilly and Co 2.73% to 2.43%; Johnson & Johnson 8.09% to 7.81%; AbbVie Inc 3.53% to 3.25%; Amgen Inc 3.04% to 2.76%; Gilead Sciences Inc 1.85% to 1.58%. New: Seagen Inc (0.44%). Gone: Seattle Genetics Inc (0.42%), Immunomedics Inc (0.16%), Momenta Pharmaceuticals Inc (0.07%), Principia Biopharma Inc (0.04%), Chicago Mercantile Exchange (0.02%), Aimmune Therapeutics Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 18 Dec 2020 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/356 positions became 403: 61 added (1.51% of the fund), 14 dropped (1.46%). Turnover proxy 7.4%. Largest increases: AbbVie Inc 2.79% to 3.53%; Thermo Fisher Scientific Inc 3.08% to 3.48%; Regeneron Pharmaceuticals Inc 0.98% to 1.34%; Danaher Corp 2.34% to 2.69%; Intuitive Surgical Inc 1.35% to 1.67%; IDEXX Laboratories Inc 0.55% to 0.71%. Largest decreases: Johnson & Johnson 9.05% to 8.09%; Gilead Sciences Inc 2.44% to 1.85%; Bristol-Myers Squibb Co 3.27% to 2.79%; Pfizer Inc 4.87% to 4.49%; Merck & Co Inc 4.63% to 4.29%; Eli Lilly and Co 3.06% to 2.73%. New: Moderna Inc (0.42%), Avantor Inc (0.2%), Novavax Inc (0.16%), Livongo Health Inc (0.1%), Inovio Pharmaceuticals Inc (0.06%), Adaptive Biotechnologies Corp (0.06%). Gone: Allergan PLC (1.41%), Portola Pharmaceuticals Inc (0.01%), Progenics Pharmaceuticals Inc (0.01%), Stemline Therapeutics Inc (0.01%), Cross Country Healthcare Inc (0.01%), Cutera Inc (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 21 Sep 2020 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/359 positions became 356: 3 added (0.04% of the fund), 6 dropped (0.1%). Turnover proxy 4.6%. Largest increases: Gilead Sciences Inc 1.84% to 2.44%; UnitedHealth Group Inc 5.95% to 6.35%; Regeneron Pharmaceuticals Inc 0.63% to 0.98%; Amgen Inc 2.98% to 3.26%; Eli Lilly and Co 2.8% to 3.06%; DexCom Inc 0.51% to 0.7%. Largest decreases: Medtronic PLC 3.57% to 3%; Merck & Co Inc 5.04% to 4.63%; CVS Health Corp 2.03% to 1.84%; Stryker Corp 1.63% to 1.44%; HCA Healthcare Inc 0.87% to 0.68%; Boston Scientific Corp 1.34% to 1.2%. New: Chicago Mercantile Exchange (0.02%), Option Care Health Inc (0.01%), Precigen Inc (0.01%). Gone: Ra Pharmaceuticals Inc (0.03%), Forty Seven Inc (0.02%), Dermira Inc (0.02%), Option Care Health Inc (0.01%), Intrexon Corp (0.01%), Diplomat Pharmacy Inc (0.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 26 Jun 2020 12:00:00 GMThttps://themulden.com/funds/fhlc/https://themulden.com/funds/fhlc/369 positions became 359: 19 added (0.3% of the fund), 29 dropped (2.61%). Turnover proxy 5.6%. Largest increases: Bristol-Myers Squibb Co 2.27% to 3.4%; Johnson & Johnson 8.48% to 9.05%; Eli Lilly & Co 2.41% to 2.8%; Centene Corp 0.53% to 0.84%; Danaher Corp 2.15% to 2.32%; DexCom Inc 0.34% to 0.51%. Largest decreases: Pfizer Inc 5.15% to 4.74%; Merck & Co Inc 5.4% to 5.04%; Biogen Inc 1.4% to 1.14%; Amgen Inc 3.15% to 2.98%; Edwards Lifesciences Corp 1.2% to 1.05%; Stryker Corp 1.76% to 1.63%. New: Envista Holdings Corp (0.08%), Kodiak Sciences Inc (0.04%), Turning Point Therapeutics Inc (0.02%), Silk Road Medical Inc (0.02%), Change Healthcare Inc (0.02%), CryoPort Inc (0.01%). Gone: Celgene Corp (1.84%), WellCare Health Plans Inc (0.36%), Medicines Co/The (0.09%), Spark Therapeutics Inc (0.09%), Cambrex Corp (0.05%), Genomic Health Inc (0.04%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Mar 2020 12:00:00 GMT